RD

Rajen Dhirubhai Shah

Active Director Whole-Time Director DIN 00051964
DIN 00051964 First appointment Mar 2001 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Mar 2001
Shareholding value •••• Premium profile

About Rajen Dhirubhai Shah

Data last updated:

Rajen Dhirubhai Shah is a Whole-Time Director at Raptim Research Private Limited (since 2004), Designated Partner at Citus Research Llp (since 2018) and Director at Nova Chemdrugs Private Limited (since 2001). The companies operate in Life Sciences, Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹172 Cr; the largest is Raptim Research Private Limited at ₹146 Cr (FY 2025). Earlier, Rajen Dhirubhai Shah was a Director at J B Chemicals And Pharmaceuticals Limited (2003–2013) and Director at Accela Pharmaceuticals Private Limited (2010–2022) and 2 more.

DIN 00051964
Primary Designation Whole-Time Director
Industry Life Sciences
First Appointment 11 Mar 2001
Oldest Company Age 24 yrs
Largest company Raptim Research Private Limited · ₹146 Cr (FY 2025)
Combined revenue ₹172 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raptim Research Private Limited U73100MH2002PTC136230
Whole-Time Director29 Jun 20042002₹146 Cr (FY 2025)Active
Designated Partner25 Sep 20182018₹22.91 Cr (FY 2023)Active
Nova Chemdrugs Private Limited U24232MH2001PTC108616
Director06 Dec 20012001₹3.09 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20031976₹4,208 Cr (FY 2026)Active
Director10 Nov 20102010₹10 Lakh (FY 2023)Active
Nova Containers Limited U28992MH1998PLC115026
Director11 Mar 20011998₹70,420 (FY 2016)Strike Off
Nova Machineries Private Limited U29290MH1993PTC072608
Director01 Dec 20011993₹8.8 Lakh (FY 2022)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajen Dhirubhai Shah

Directorship timeline

Open interactive timeline →
Nova Chemdrugs Private Limited
Raptim Research Private Limited
Citus Research Llp
J B Chemicals And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Rajen Dhirubhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajen Dhirubhai Shah

Rajen Dhirubhai Shah currently holds 3 directorships: Raptim Research Private Limited (Whole-Time Director, since 29 Jun 2004, revenue ₹146 Cr (FY 2025)); Citus Research Llp (Designated Partner, since 25 Sep 2018, revenue ₹22.91 Cr (FY 2023)); Nova Chemdrugs Private Limited (Director, since 06 Dec 2001, revenue ₹3.09 Cr (FY 2025)).

Rajen Dhirubhai Shah was first appointed on 11 Mar 2001 as Director at Nova Containers Limited. The most recent appointment on record is 25 Sep 2018 at Citus Research Llp.

The 3 current companies of Rajen Dhirubhai Shah that report revenue have a combined latest revenue of ₹172 Cr: Raptim Research Private Limited ₹146 Cr (FY 2025); Citus Research Llp ₹22.91 Cr (FY 2023); Nova Chemdrugs Private Limited ₹3.09 Cr (FY 2025).

Rajen Dhirubhai Shah held 4 earlier board appointments: J B Chemicals And Pharmaceuticals Limited (Director, 01 Aug 2003 to 15 Apr 2013); Accela Pharmaceuticals Private Limited (Director, 10 Nov 2010 to 19 Apr 2022); Nova Containers Limited (Director, 11 Mar 2001 to 13 Oct 2015); Nova Machineries Private Limited (Director, 01 Dec 2001 to 01 Mar 2016).

The current boards of Rajen Dhirubhai Shah's companies include Meghana Rajen Shah (Raptim Research Private Limited), Viraj Dhirubhai Shah (Raptim Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available